Skip to main content

Advertisement

Log in

Lifestyle interventions in preventing new type 2 diabetes in Asian populations

  • IM - REVIEW
  • Published:
Internal and Emergency Medicine Aims and scope Submit manuscript

Abstract

The aim of this study was to review current evidence on interventional studies aimed at the prevention of type 2 diabetes in Asian population with lifestyle interventions. Prevalence of type 2 diabetes sharply increased in most Asian countries during the last decades. This issue has now also relevant implication for Europe where different surveys are also consistently revealing an higher prevalence of type 2 diabetes and other and major CVD risk factors among subjects originating from Asian Countries than in the native population. Nutrition and lifestyle transition seem to play a role in disclosing the predisposition for the development of type 2 diabetes and great interest is now shown toward the possibility to intervene with lifestyle intervention on at risk populations. A meta-analysis of Randomized Controlled Trials showed that lifestyle interventions are highly effective also in the Asian population. All studies were, however, conducted with an individual approach based on the identification of high-risk individuals. When ethnic minority groups have to be addressed, an approach directed to the community rather than to the individual might, however, be more effective. This review reinforces the importance for policy-makers to consider the involvement of the whole community of minority immigrant groups with lifestyle intervention programs.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Goldberg R, Temprosa M, Otvos J, Brunzell J, Marcovina S, Mather K, Arakaki R, Watson K, Horton E, Barrett-Connor E (2013) Lifestyle and metformin treatment favorably influence lipoprotein subfraction distribution in the Diabetes Prevention Program. J Clin Endocrinol Metab 98(10):3989–3998. doi:10.1210/jc.2013-1452

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Pan XR, Li GW, Hu YH, Wang JX, Yang WY, An ZX, Hu ZX, Lin J, Xiao JZ, Cao HB, Liu PA, Jiang XG, Jiang YY, Wang JP, Zheng H, Zhang H, Bennett PH, Howard BV (1997) Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study. Diabetes Care 20(4):537–544. doi:10.2337/diacare.20.4.537

    Article  CAS  PubMed  Google Scholar 

  3. Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, Nathan DM, Diabetes Prevention Program Research Group (2002) Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 346(6):393–403. doi:10.1056/NEJMoa012512

    Article  CAS  PubMed  Google Scholar 

  4. Lindstrom J, Ilanne-Parikka P, Peltonen M, Aunola S, Eriksson JG, Hemio K, Hamalainen H, Harkonen P, Keinanen-Kiukaanniemi S, Laakso M, Louheranta A, Mannelin M, Paturi M, Sundvall J, Valle TT, Uusitupa M, Tuomilehto J (2006) Sustained reduction in the incidence of type 2 diabetes by lifestyle intervention: follow-up of the Finnish Diabetes Prevention Study. Lancet 368(9548):1673–1679. doi:10.1016/S0140-6736(06)69701-8

    Article  PubMed  Google Scholar 

  5. Kosaka K, Noda M, Kuzuya T (2005) Prevention of type 2 diabetes by lifestyle intervention: a Japanese trial in IGT males. Diabetes Res Clin Pract 67(2):152–162. doi:10.1016/j.diabres.2004.06.010

    Article  PubMed  Google Scholar 

  6. Ramachandran A, Snehalatha C, Mary S, Mukesh B, Bhaskar AD, Vijay V (2006) The Indian Diabetes Prevention Programme shows that lifestyle modification and metformin prevent type 2 diabetes in Asian Indian subjects with impaired glucose tolerance (IDPP-1). Diabetologia 49(2):289–297. doi:10.1007/s00125-005-0097-z

    Article  CAS  PubMed  Google Scholar 

  7. Bushman B (2014) Promoting exercise as medicine for prediabetes and prehypertension. Curr Sports Med Rep 13(4):233–239. doi:10.1249/jsr.0000000000000066

    Article  PubMed  Google Scholar 

  8. Lambert EV, Bull F (2014) Public health recommendations for physical activity in the prevention of type 2 diabetes mellitus. Med Sport Sci 60:130–140. doi:10.1159/000357343

    Article  PubMed  Google Scholar 

  9. Fernandes RA, Coelho ESMJ, Spiguel Lima MC, Cayres SU, Codogno JS, Lira FS (2015) Possible underestimation by sports medicine of the effects of early physical exercise practice on the prevention of diseases in adulthood. Curr Diabetes Rev 11(3):201–205

    Article  PubMed  Google Scholar 

  10. Hopper I, Billah B, Skiba M, Krum H (2011) Prevention of diabetes and reduction in major cardiovascular events in studies of subjects with prediabetes: meta-analysis of randomised controlled clinical trials. Eur J Cardiovasc Prev Rehabil 18(6):813–823. doi:10.1177/1741826711421687

    Article  PubMed  Google Scholar 

  11. Schellenberg ES, Dryden DM, Vandermeer B, Ha C, Korownyk C (2013) Lifestyle interventions for patients with and at risk for type 2 diabetes: a systematic review and meta-analysis. Ann Intern Med 159(8):543–551. doi:10.7326/0003-4819-159-8-201310150-00007

    Article  PubMed  Google Scholar 

  12. Hamilton MT, Hamilton DG, Zderic TW (2014) Sedentary behavior as a mediator of type 2 diabetes. Med Sport Sci 60:11–26. doi:10.1159/000357332

    Article  PubMed  PubMed Central  Google Scholar 

  13. Saaristo T, Moilanen L, Korpi-Hyovalti E, Vanhala M, Saltevo J, Niskanen L, Jokelainen J, Peltonen M, Oksa H, Tuomilehto J, Uusitupa M, Keinanen-Kiukaanniemi S (2010) Lifestyle intervention for prevention of type 2 diabetes in primary health care one-year follow-up of the Finnish National Diabetes Prevention Program (FIN-D2D). Diabetes Care 33(10):2146–2151. doi:10.2337/Dc10-0410

    Article  PubMed  PubMed Central  Google Scholar 

  14. Tuomilehto J, Schwarz P, Lindstrom J (2011) Long-term benefits from lifestyle interventions for type 2 diabetes prevention time to expand the efforts. Diabetes Care 34:S210–S214. doi:10.2337/Dc11-S222

    Article  PubMed  PubMed Central  Google Scholar 

  15. Assoc AD (2013) Economic costs of diabetes in the US in 2012. Diabetes Care 36(4):1033–1046. doi:10.2337/Dc12-2625

    Article  Google Scholar 

  16. Hermansen K, Baekdal TA, During M, Pietraszek A, Mortensen LS, Jorgensen H, Flint A (2013) Liraglutide suppresses postprandial triglyceride and apolipoprotein B48 elevations after a fat-rich meal in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled, cross-over trial. Diabetes Obes Metab 15(11):1040–1048. doi:10.1111/dom.12133

    Article  CAS  PubMed  Google Scholar 

  17. McKeigue PM, Marmot MG, Syndercombe Court YD, Cottier DE, Rahman S, Riemersma RA (1988) Diabetes, hyperinsulinaemia, and coronary risk factors in Bangladeshis in east London. Br Heart J 60(5):390–396

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Shai I, Jiang R, Manson JE, Stampfer MJ, Willett WC, Colditz GA, Hu FB (2006) Ethnicity, obesity, and risk of type 2 diabetes in women—a 20-year follow-up study. Diabetes Care 29(7):1585–1590. doi:10.2337/Dc06-0057

    Article  PubMed  Google Scholar 

  19. Khoo CM, Sairazi S, Taslim S, Gardner D, Wu Y, Lee J, van Dam RM, Tai ES (2011) Ethnicity modifies the relationships of insulin resistance, inflammation, and adiponectin with obesity in a multiethnic Asian population. Diabetes Care 34(5):1120–1126. doi:10.2337/Dc10-2097

    Article  PubMed  PubMed Central  Google Scholar 

  20. Wang C, Li J, Xue H, Li Y, Huang J, Mai J, Chen J, Cao J, Wu X, Guo D, Yu L, Gu D (2014) Type 2 diabetes mellitus incidence in Chinese: contributions of overweight and obesity. Diabetes Res Clin Pract. doi:10.1016/j.diabres.2014.09.059

    PubMed Central  Google Scholar 

  21. Ryden L, Grant PJ, Anker SD, Berne C, Cosentino F, Danchin N, Deaton C, Escaned J, Hammes HP, Huikuri H, Marre M, Marx N, Mellbin L, Ostergren J, Patrono C, Seferovic P, Uva MS, Taskinen MR, Tendera M, Tuomilehto J, Valensi P, Zamorano JL (2013) ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD. Eur Heart J 34(39):3035–3087. doi:10.1093/eurheartj/eht108

    Article  PubMed  Google Scholar 

  22. Rechel B, Mladovsky P, Ingleby D, Mackenbach JP, McKee M (2013) Migration and health in an increasingly diverse Europe. Lancet 381(9873):1235–1245. doi:10.1016/S0140-6736(12)62086-8

    Article  PubMed  Google Scholar 

  23. Barba C, Cavalli-Sforza T, Cutter J, Darnton-Hill I, Deurenberg P, Deurenberg-Yap M, Gill T, James P, Ko G, Miu AH, Kosulwat V, Kumanyika S, Kurpad A, Mascie-Taylor N, Moon HK, Nishida C, Noor MI, Reddy KS, Rush E, Schultz JT, Seidell J, Stevens J, Swinburn B, Tan K, Weisell R, Wu ZS, Yajnik CS, Yoshiike N, Zimmet P, Consultation WE (2004) Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet 363(9403):157–163

    Article  Google Scholar 

  24. Chiu M, Austin PC, Manuel DG, Shah BR, Tu JV (2011) Deriving ethnic-specific BMI cutoff points for assessing diabetes risk. Diabetes Care 34(8):1741–1748. doi:10.2337/dc10-2300

    Article  PubMed  PubMed Central  Google Scholar 

  25. Carulli L, Rondinella S, Lombardini S, Canedi I, Loria P, Carulli N (2005) Review article: diabetes, genetics and ethnicity. Aliment Pharmacol Ther 22:16–19. doi:10.1111/j.1365-2036.2005.02588.x

    Article  PubMed  Google Scholar 

  26. Yajnik CS, Lubree HG, Rege SS, Naik SS, Deshpande JA, Deshpande SS, Joglekar CV, Yudkin JS (2002) Adiposity and hyperinsulinemia in Indians are present at birth. J Clin Endocr Metab 87(12):5575–5580. doi:10.1210/jc.2002-020434

    Article  CAS  PubMed  Google Scholar 

  27. Mckeigue PM, Pierpoint T, Ferrie JE, Marmot MG (1992) Relationship of glucose-intolerance and hyperinsulinemia to body-fat pattern in South Asians and Europeans. Diabetologia 35(8):785–791

    CAS  PubMed  Google Scholar 

  28. Who (2004) Appropriate body-mass index in Asian populations and its implications for policy and intervention strategies. Lancet 363(9412):902

    Article  Google Scholar 

  29. Misra A, Chowbey P, Makkar BM, Vikram NK, Wasir JS, Chadha D, Joshi SR, Sadikot S, Gupta R, Gulati S, Munjal YP, Concensus G (2009) Consensus statement for diagnosis of obesity, abdominal obesity and the metabolic syndrome for Asian Indians and recommendations for physical activity, medical and surgical management. J Assoc Phys India 57:163–170

    CAS  Google Scholar 

  30. Bei-Fan Z, Working CMAG (2002) Predictive values of body mass index and waist circumference for risk factors of certain related diseases in Chinese adults: study on optimal cut-off points of body mass index and waist circumference in Chinese adults. Asia Pac J Clin Nutr 11:S685–S693. doi:10.1046/j.1440-6047.11.s8.9.x

    Article  Google Scholar 

  31. Hsu WC, Araneta MRG, Kanaya AM, Chiang JL, Fujimoto W (2015) BMI cut points to identify at-risk Asian Americans for type 2 diabetes screening. Diabetes Care 38(1):150–158. doi:10.2337/Dc14-2391

    Article  PubMed  PubMed Central  Google Scholar 

  32. Edelstein SL, Knowler WC, Bain RP, Andres R, BarrettConnor EL, Dowse GK, Haffner SM, Pettitt DJ, Sorkin JD, Muller DC, Collins VR, Hamman RF (1997) Predictors of progression from impaired glucose tolerance to NIDDM—an analysis of six prospective studies. Diabetes 46(4):701–710. doi:10.2337/diabetes.46.4.701

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  33. Shaw JA, Zimmet PZ, de Courten M, Dowse GK, Chitson P, Gareeboo H, Hemraj F, Fareed D, Tuomilehto J, Alberti KGMM (1999) Impaired fasting glucose or impaired glucose tolerance—what best predicts future diabetes in Mauritius? Diabetes Care 22(3):399–402. doi:10.2337/diacare.22.3.399

    Article  CAS  PubMed  Google Scholar 

  34. Shaw JE, de Courten M, Boyko EJ, Zimmet PZ (1999) Impact of new diagnostic criteria for diabetes on different populations. Diabetes Care 22(5):762–766. doi:10.2337/diacare.22.5.762

    Article  CAS  PubMed  Google Scholar 

  35. Gabir MM, Hanson RL, Dabelea D, Imperatore G, Roumain J, Bennett PH, Knowler WC (2000) The 1997 American Diabetes Association and 1999 World Health Organization criteria for hyperglycemia in the diagnosis and prediction of diabetes. Diabetes Care 23(8):1108–1112. doi:10.2337/diacare.23.8.1108

    Article  CAS  PubMed  Google Scholar 

  36. de Vegt F, Dekker JM, Jager A, Hienkens E, Kostense PJ, Stehouwer CDA, Nijpels G, Bouter LM, Heine RJ (2001) Relation of impaired fasting and postload glucose with incident type 2 diabetes in a Dutch population—the Hoorn study. JAMA 285(16):2109–2113. doi:10.1001/jama.285.16.2109

    Article  PubMed  Google Scholar 

  37. Gerstein HC, Santaguida P, Raina P, Morrison KM, Balion C, Hunt D, Yazdi H, Booker L (2007) Annual incidence and relative risk of diabetes in people with various categories of dysglycemia: a systematic overview and meta-analysis of prospective studies. Diabetes Res Clin Pract 78(3):305–312. doi:10.1016/j.diabres.2007.05.004

    Article  PubMed  Google Scholar 

  38. Harris MI, Flegal KM, Cowie CC, Eberhardt MS, Goldstein DE, Little RR, Wiedmeyer HM, Byrd-Holt DD (1998) Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in US adults—the Third National Health and Nutrition Examination Survey, 1988–1994. Diabetes Care 21(4):518–524. doi:10.2337/diacare.21.4.518

    Article  CAS  PubMed  Google Scholar 

  39. Stern MP, Williams K, Haffner SA (2002) Identification of persons at high risk for type 2 diabetes mellitus: do we need the oral glucose tolerance test? Ann Intern Med 136(8):575–581

    Article  PubMed  Google Scholar 

  40. Modesti PA, Bianchi S, Borghi C, Cameli M, Capasso G, Ceriello A, Ciccone MM, Germano G, Maiello M, Muiesan ML, Novo S, Padeletti L, Palmiero P, Pillon S, Rotella CM, Saba PS, Scicchitano P, Trimarco B, Volpe M, Pedrinelli R, Di Biase M (2014) Cardiovascular health in migrants: current status and issues for prevention. A collaborative multidisciplinary task force report. J Cardiovasc Med 15(9):683–692. doi:10.2459/Jcm.0000000000000069

    Article  Google Scholar 

  41. American Diabetes A (2013) Standards of medical care in diabetes–2013. Diabetes Care 36(Suppl 1):S11–S66. doi:10.2337/dc13-S011

    Article  Google Scholar 

  42. Kengne AP, Beulens JWJ, Peelen LM, Moons KGM, van der Schouw YT, Schulze MB, Spijkerman AMW, Griffin SJ, Grobbee DE, Palla L, Tormo MJ, Arriola L, Barengo NC, Barricarte A, Boeing H, Bonet C, Clavel-Chapelon F, Dartois L, Fagherazzi G, Franks PW, Huerta JM, Kaaks R, Key TJ, Khaw KT, Li KR, Muhlenbruch K, Nilsson PM, Overvad K, Overvad TF, Palli D, Panico S, Quiros JR, Rolandsson O, Roswall N, Sacerdote C, Sanchez MJ, Slimani N, Tagliabue G, Tjonneland A, Tumino R, van der A DL, Forouhi NG, Sharp SJ, Langenberg C, Riboli E, Wareham NJ (2014) Non-invasive risk scores for prediction of type 2 diabetes (EPIC-InterAct): a validation of existing models. Lancet Diabetes Endocrinol 2(1):19–29. doi:10.1016/S2213-8587(13)70103-7

    Article  PubMed  Google Scholar 

  43. Lindstrom J, Tuomilehto J (2003) The diabetes risk score—a practical tool to predict type 2 diabetes risk. Diabetes Care 26(3):725–731. doi:10.2337/diacare.26.3.725

    Article  PubMed  Google Scholar 

  44. Buijsse B, Simmons RK, Griffin SJ, Schulze MB (2011) Risk assessment tools for identifying individuals at risk of developing type 2 diabetes. Epidemiol Rev 33(1):46–62. doi:10.1093/epirev/mxq019

    Article  PubMed  PubMed Central  Google Scholar 

  45. Collins GS, Mallett S, Omar O, Yu LM (2011) Developing risk prediction models for type 2 diabetes: a systematic review of methodology and reporting. BMC Med. doi:10.1186/1741-7015-9-103

    PubMed  PubMed Central  Google Scholar 

  46. Noble D, Mathur R, Dent T, Meads C, Greenhalgh T (2011) Risk models and scores for type 2 diabetes: systematic review. BMJ 343:d7163. doi:10.1136/bmj.d7163

    Article  PubMed  PubMed Central  Google Scholar 

  47. Abbasi A, Peelen LM, Corpeleijn E, van der Schouw YT, Stolk RP, Spijkerman AMW, van der A DL, Moons KGM, Navis G, Bakker SJL, Beulens JWJ (2012) Prediction models for risk of developing type 2 diabetes: systematic literature search and independent external validation study. BMJ. doi:10.1136/bmj.e5900

    PubMed  PubMed Central  Google Scholar 

  48. Schmidt MI, Duncan BB, Bang H, Pankow JS, Ballantyne CM, Golden SH, Folsom AR, Chambless LE (2005) Identifying individuals at high risk for diabetes—the Atherosclerosis Risk in Communities study. Diabetes Care 28(8):2013–2018. doi:10.2337/diacare.28.8.2013

    Article  PubMed  Google Scholar 

  49. Kahn HS, Cheng YJ, Thompson TJ, Imperatore G, Gregg EW (2009) Two risk-scoring systems for predicting incident diabetes mellitus in US adults age 45–64 years. Ann Intern Med 150(11):741–751

    Article  PubMed  Google Scholar 

  50. Chen L, Magliano DJ, Balkau B, Colagiuri S, Zimmet PZ, Tonkin AM, Mitchell P, Phillips PJ, Shaw JE (2010) AUSDRISK: an Australian type 2 diabetes risk assessment tool based on demographic, lifestyle and simple anthropometric measures. Med J Aust 192(4):197–202

    PubMed  Google Scholar 

  51. Rosella LC, Manuel DG, Burchill C, Stukel TA, team ftP-D (2011) A population-based risk algorithm for the development of diabetes: development and validation of the Diabetes Population Risk Tool (DPoRT). J Epidemiol Commun Health 65(7):613–620. doi:10.1136/jech.2009.102244

    Article  Google Scholar 

  52. Hippisley-Cox J, Coupland C, Robson J, Sheikh A, Brindle P (2009) Predicting risk of type 2 diabetes in England and Wales: prospective derivation and validation of QDScore. BMJ. doi:10.1136/bmj.b880

    Google Scholar 

  53. Mann DM, Bertoni AG, Shimbo D, Carnethon MR, Chen HY, Jenny NS, Muntner P (2010) Comparative validity of 3 diabetes mellitus risk prediction scoring models in a multiethnic US cohort. Am J Epidemiol 171(9):980–988. doi:10.1093/Aje/Kwq030

    Article  PubMed  PubMed Central  Google Scholar 

  54. Merlotti C, Morabito A, Pontiroli AE (2014) Prevention of type 2 diabetes; a systematic review and meta-analysis of different intervention strategies. Diabetes Obes Metab 16(8):719–727. doi:10.1111/dom.12270

    Article  CAS  PubMed  Google Scholar 

  55. Saito T, Watanabe M, Nishida J, Izumi T, Omura M, Takagi T, Fukunaga R, Bandai Y, Tajima N, Nakamura Y, Ito M (2011) Lifestyle modification and prevention of type 2 diabetes in overweight Japanese with impaired fasting glucose levels A Randomized Controlled Trial. Arch Intern Med 171(15):1352–1360

    Article  PubMed  Google Scholar 

  56. Sakane N, Sato J, Tsushita K, Tsujii S, Kotani K, Tsuzaki K, Tominaga M, Kawazu S, Sato Y, Usui T, Kamae I, Yoshida T, Kiyohara Y, Sato S, Kuzuya H (2011) Prevention of type 2 diabetes in a primary healthcare setting: three-year results of lifestyle intervention in Japanese subjects with impaired glucose tolerance. BMC Public Health 11(1):40. doi:10.1186/1471-2458-11-40

    Article  PubMed  PubMed Central  Google Scholar 

  57. Iqbal Hydrie MZ, Basit A, Shera AS, Hussain A (2012) Effect of intervention in subjects with high risk of diabetes mellitus in pakistan. J Nutr Metab 2012:867604. doi:10.1155/2012/867604

    Article  PubMed  PubMed Central  Google Scholar 

  58. Ramachandran A, Snehalatha C, Ram J, Selvam S, Simon M, Nanditha A, Shetty AS, Godsland IF, Chaturvedi N, Majeed A, Oliver N, Toumazou C, Alberti KG, Johnston DG (2013) Effectiveness of mobile phone messaging in prevention of type 2 diabetes by lifestyle modification in men in India: a prospective, parallel-group, randomised controlled trial. Lancet Diabetes Endocrinol 1(3):191–198. doi:10.1016/S2213-8587(13)70067-6

    Article  PubMed  Google Scholar 

  59. Bhopal RS, Douglas A, Wallia S, Forbes JF, Lean ME, Gill JM, McKnight JA, Sattar N, Sheikh A, Wild SH, Tuomilehto J, Sharma A, Bhopal R, Smith JB, Butcher I, Murray GD (2014) Effect of a lifestyle intervention on weight change in south Asian individuals in the UK at high risk of type 2 diabetes: a family-cluster randomised controlled trial. Lancet Diabetes Endocrinol 2(3):218–227. doi:10.1016/s2213-8587(13)70204-3

    Article  PubMed  Google Scholar 

  60. National_Diabetes_Research_Group (1981) A mass survey of diabetes mellitus in a population of 300,000 in 14 provinces and municipalities in China (author’s transl). Zhonghua Nei Ke Za Zhi 20(11):678–683

    Google Scholar 

  61. Pan XR, Yang WY, Li GW, Liu J (1997) Prevalence of diabetes and its risk factors in China, 1994. Diabetes Care 20(11):1664–1669. doi:10.2337/diacare.20.11.1664

    Article  CAS  PubMed  Google Scholar 

  62. Li GW, Zhang P, Wang JP, Gregg EW, Yang WY, Gong QH, Li H, Li HL, Jiang YY, An YL, Shuai Y, Zhang B, Zhang JL, Thompson TJ, Gerzoff RB, Roglic G, Hu YH, Bennett PH (2008) The long-term effect of lifestyle interventions to prevent diabetes in the China Da Qing Diabetes Prevention Study: a 20-year follow-up study. Lancet 371(9626):1783–1789. doi:10.1016/S0140-6736(08)60766-7

    Article  PubMed  Google Scholar 

  63. Xu Y, Wang L, He J, Bi Y, Li M, Wang T, Wang L, Jiang Y, Dai M, Lu J, Xu M, Li Y, Hu N, Li J, Mi S, Chen CS, Li G, Mu Y, Zhao J, Kong L, Chen J, Lai S, Wang W, Zhao W, Ning G (2013) Prevalence and control of diabetes in Chinese adults. JAMA 310(9):948–959. doi:10.1001/jama.2013.168118

    Article  CAS  PubMed  Google Scholar 

  64. Modesti PA (2015) Ethnicity: new challenge for cardiovascular prevention in Europe. Hypertension 66(3):464–465. doi:10.1161/HYPERTENSIONAHA.115.05777

    Article  CAS  PubMed  Google Scholar 

  65. Gillies CL, Lambert PC, Abrams KR, Sutton AJ, Cooper NJ, Hsu RT, Davies MJ, Khunti K (2008) Different strategies for screening and prevention of type 2 diabetes in adults: cost effectiveness analysis. BMJ 336(7654):1180. doi:10.1136/bmj.39545.585289.25

    Article  PubMed  PubMed Central  Google Scholar 

  66. Admiraal WM, Vlaar EM, Nierkens V, Holleman F, Middelkoop BJ, Stronks K, van Valkengoed IG (2013) Intensive lifestyle intervention in general practice to prevent type 2 diabetes among 18–60-year-old South Asians: 1-year effects on the weight status and metabolic profile of participants in a randomized controlled trial. PLoS One 8(7):e68605. doi:10.1371/journal.pone.0068605

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  67. Rose G (1981) Strategy of prevention: lessons from cardiovascular disease. Br Med J (Clin Res Ed) 282(6279):1847–1851

    Article  CAS  Google Scholar 

  68. Latham K, Wu B (2013) Chinese immigration into the EU: new trends, dynamics and implications. 1–65. http://www.chathamhouse.org/sites/files/chathamhouse/public/Research/Asia/0313ecran_lathamwu.pdf

  69. Zhou M, Astell-Burt T, Bi Y, Feng X, Jiang Y, Li Y, Page A, Wang L, Xu Y, Wang L, Zhao W, Ning G (2015) Geographical variation in diabetes prevalence and detection in china: multilevel spatial analysis of 98,058 adults. Diabetes Care 38(1):72–81. doi:10.2337/dc14-1100

    Article  PubMed  PubMed Central  Google Scholar 

  70. Modesti PA, Han Y, Jing Y, Xiaoling W, Mengyue Z, Zihua Y, Jia G, Perruolo E, Bini L, Camera M, Biggeri A, Rapi S, Hongsheng C, Li Z, Zengli W, Jianbin H, Xiaoyue Z, Zhao D (2014) Design and arrangement of the CHIP (CHinese In Prato) study. Epidemiol Prev 38(6):357–363

    PubMed  Google Scholar 

  71. Stuart-Shor EM, Berra KA, Kamau MW, Kumanyika SK (2012) Behavioral strategies for cardiovascular risk reduction in diverse and underserved racial/ethnic groups. Circulation 125(1):171–184. doi:10.1161/circulationaha.110.968495

    Article  PubMed  PubMed Central  Google Scholar 

  72. Grace C, Begum R, Subhani S, Kopelman P, Greenhalgh T (2008) Prevention of type 2 diabetes in British Bangladeshis: qualitative study of community, religious, and professional perspectives. BMJ 337:a1931. doi:10.1136/bmj.a1931

    Article  PubMed  PubMed Central  Google Scholar 

  73. Artinian NT, Fletcher GF, Mozaffarian D, Kris-Etherton P, Van Horn L, Lichtenstein AH, Kumanyika S, Kraus WE, Fleg JL, Redeker NS, Meininger JC, Banks J, Stuart-Shor EM, Fletcher BJ, Miller TD, Hughes S, Braun LT, Kopin LA, Berra K, Hayman LL, Ewing LJ, Ades PA, Durstine JL, Houston-Miller N, Burke LE, American Heart Association Prevention Committee of the Council on Cardiovascular N (2010) Interventions to promote physical activity and dietary lifestyle changes for cardiovascular risk factor reduction in adults: a scientific statement from the American Heart Association. Circulation 122(4):406–441. doi:10.1161/CIR.0b013e3181e8edf1

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Pietro Amedeo Modesti.

Ethics declarations

Conflict of interest

None.

Statement of human and animal rights

This article does not contain any studies with human participants or animals performed by any of the authors.

Informed consent

For this type of study formal consent is not required.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary material 1 (DOCX 49 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Modesti, P.A., Galanti, G., Cala’, P. et al. Lifestyle interventions in preventing new type 2 diabetes in Asian populations. Intern Emerg Med 11, 375–384 (2016). https://doi.org/10.1007/s11739-015-1325-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11739-015-1325-2

Keywords

Navigation